Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07673146 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Probing Gut-Brain Communication in Parkinson's Disease

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 1, 2026 to Jan 1, 2027
    • Eligibility criteria shortened, about 14 words
  2. Interventions: UROstim (Device) to Sham taVNS (Device), taVNS (Device)v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Administering transcutaneous vagus nerve stimulation in patients with Parkinson's disease to see how it affects stomach and brain activity.
Trial Details
NCT Number NCT07673146
Lead Sponsor Spaulding Rehabilitation Hospital
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)		 Parkinson Disease (PD)
Related terms Parkinson Disease
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov